Consistent with in vitro results, FPN1 KD or hepcidin treatment blocked tumor growth compared with the control group; this inhibitory effect was reversed by Lip-1 treatment (Fig. 6N–R). The gene discussed is SLC40A1; the disease is neoplasm.